CoChat

Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2

Open access
Early, James O., Menon, Deepthi, Wyse, Cathy A., Cervantes-Silva, Mariana P., Zaslona, Zbigniew, Carroll, Richard G., Palsson-McDermott, Eva M., Angiari, Stefano, Ryan, Dylan G., Corcoran, Sarah E., Timmons, George, Geiger, Sarah S., Fitzpatrick, Darren J., O’Connell, Daniel, Xavier, Ramnik J., Hokamp, Karsten, O’Neill, Luke A. J., Curtis, Annie M. · 2018 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Significance: The molecular clock provides an anticipatory mechanism, allowing organisms to prepare and respond to daily changes in the external environment. The response of the innate immune system to pathogenic threats is dependent on time of day; however, the molecular mechanisms underlying this have yet to be fully uncovered. We observe that the core molecular clock component, BMAL1, is crucial in promoting an antioxidant response in myeloid cells. Deletion of Bmal1 in macrophages disrupts NRF2 activity, facilitating accumulation of reactive oxygen species and the proinflammatory cytokine, IL-1β. Thus the molecular clock directly controls NRF2 transcriptional activity and antioxidant capacity to regulate IL-1β in myeloid cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1800431115

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Rhythms in NRF2 levels and activity are disrupted with Bmal1 deletion. Bmal1+/+ and Bmal1−/− BMDMs were analyzed by TF-Seq. Bar charts reveal the relative activity of NRF2 in Bmal1+/+ and Bmal1−/− BMDMs following (A) 1 or (B) 4 h of LPS stimulation (n = 3). (C) Wild-type BMDMs were lysed and the samples were exposed to biotinylated primer sequences for the E-box site located in the Nrf2 promoter (WT E-box) or a mutated control of the E-box. The sequences were then isolated using streptavidin beads before performing an immunoblot for BMAL1. (D) Peritoneal cells were isolated from wild-type mice at 4-h intervals (ZT0, ZT4, ZT8, ZT12, ZT16, and ZT20) and Nrf2 mRNA was measured by qPCR. A cosinor regression model was used to test the null hypothesis that the amplitude of expression = 0. The presence of the red line indicates the presence of a significant rhythm (n= 3–6). (E) Bmal1+/+ and Bmal1−/− BMDMs were synchronized using 50% horse serum. RNA was extracted at 4-h intervals for 36 h and Nrf2 mRNA was measured by qPCR. A cosinor regression model was used to test the null hypothesis that the amplitude of expression = 0. The presence of the red line indicates the presence of a significant rhythm (n = 3). (F) Nrf2 mRNA was measured by qPCR in Bmal1+/+ and Bmal1−/− BMDMs following 24 h of LPS (100 ng/mL) (n = 4). (G) Immunoblot of NRF2 levels following 24 h of LPS (100 ng/mL) in Bmal1+/+ and Bmal1−/− BMDMs. Immunoblots are a representative of at least three independent experiments. Values provided below each lane indicate relative densitometry of each band. Statistical significance in graphs A and B was determined by false discovery rate (FDR); in D and E, by establishing a cosinor regression model; and in graph F, by one-way ANOVA. ***P ≤ 0.001.
Fig. 1. Rhythms in NRF2 levels and activity are disrupted with Bmal1 deletion. Bmal1+/+ and Bmal1−/− BMDMs were analyzed by TF-Seq. Bar charts reveal the relative activity of NRF2 in Bmal1+/+ and Bmal1−/− BMDMs following (A) 1 or (B) 4 h of LPS stimulation (n = 3). (C) Wild-type BMDMs were lysed and the samples were exposed to biotinylated primer sequences for the E-box site located in the Nrf2 promoter (WT E-box) or a mutated control of the E-box. The sequences were then isolated using streptavidin beads before performing an immunoblot for BMAL1. (D) Peritoneal cells were isolated from wild-type mice at 4-h intervals (ZT0, ZT4, ZT8, ZT12, ZT16, and ZT20) and Nrf2 mRNA was measured by qPCR. A cosinor regression model was used to test the null hypothesis that the amplitude of expression = 0. The presence of the red line indicates the presence of a significant rhythm (n= 3–6). (E) Bmal1+/+ and Bmal1−/− BMDMs were synchronized using 50% horse serum. RNA was extracted at 4-h intervals for 36 h and Nrf2 mRNA was measured by qPCR. A cosinor regression model was used to test the null hypothesis that the amplitude of expression = 0. The presence of the red line indicates the presence of a significant rhythm (n = 3). (F) Nrf2 mRNA was measured by qPCR in Bmal1+/+ and Bmal1−/− BMDMs following 24 h of LPS (100 ng/mL) (n = 4). (G) Immunoblot of NRF2 levels following 24 h of LPS (100 ng/mL) in Bmal1+/+ and Bmal1−/− BMDMs. Immunoblots are a representative of at least three independent experiments. Values provided below each lane indicate relative densitometry of each band. Statistical significance in graphs A and B was determined by false discovery rate (FDR); in D and E, by establishing a cosinor regression model; and in graph F, by one-way ANOVA. ***P ≤ 0.001.CC BY-NC-ND · PubMed Central
Fig. 2. NRF2 antioxidant targets are decreased with Bmal1 deletion. (A) Hmox1, (B) Gsr, and (C) Nqo1 mRNA was measured by qPCR in wild-type BMDMs transfected with scrambled siRNA or siRNA targeting Nrf2 following 24 h of LPS (n = 4–6). (D) Hmox1, (E) Gsr, and (F) Nqo1 mRNA was measured by qPCR in Bmal1+/+ and Bmal1−/− BMDMs following 24 h of LPS (n = 4–6). (G) Bmal1+/+ and Bmal1−/− BMDMs were left untreated or treated with LPS for 24 h before measuring total cell levels of GSH by luminescence (n = 3). All graphs displayed were analyzed by one-way ANOVA. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.
Fig. 2. NRF2 antioxidant targets are decreased with Bmal1 deletion. (A) Hmox1, (B) Gsr, and (C) Nqo1 mRNA was measured by qPCR in wild-type BMDMs transfected with scrambled siRNA or siRNA targeting Nrf2 following 24 h of LPS (n = 4–6). (D) Hmox1, (E) Gsr, and (F) Nqo1 mRNA was measured by qPCR in Bmal1+/+ and Bmal1−/− BMDMs following 24 h of LPS (n = 4–6). (G) Bmal1+/+ and Bmal1−/− BMDMs were left untreated or treated with LPS for 24 h before measuring total cell levels of GSH by luminescence (n = 3). All graphs displayed were analyzed by one-way ANOVA. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.CC BY-NC-ND · PubMed Central
Fig. 3. Diurnal rhythms in ROS regulation. (A) Peritoneal cells were isolated from wild-type mice at ZT8 and ZT20. Cells were stained with a CD11b+ antibody and CellROX stain. ROS levels were then measured by mean fluoresence intensity (MFI) in the myeloid population by flow cytometry (n = 4–6). (B) Peritoneal cells were isolated from wild-type mice at ZT0 and ZT12. RNA was extracted and gene expression panels were used to measure fold change of oxidative stress pathway genes at ZT12 versus ZT0 (n = 3). (C) Bmal1+/+ and Bmal1−/− BMDMs were treated with LPS (100 ng/mL) for 24 h before staining with CellROX. ROS was then measured via flow cytometry (n = 4). (D) Bmal1+/+ and Bmal1−/− BMDMs were untreated or treated with LPS (100 ng/mL) for 24 h before staining with CellROX and MitoTracker green. The cells were imaged using confocal microscopy. Image shown is a representative of at least three independent experiments. Statistical significance of graph A was determined by unpaired Student’s t test. Statistical significance of C was determined by one-way ANOVA. *P ≤ 0.05 and **P ≤ 0.01.
Fig. 3. Diurnal rhythms in ROS regulation. (A) Peritoneal cells were isolated from wild-type mice at ZT8 and ZT20. Cells were stained with a CD11b+ antibody and CellROX stain. ROS levels were then measured by mean fluoresence intensity (MFI) in the myeloid population by flow cytometry (n = 4–6). (B) Peritoneal cells were isolated from wild-type mice at ZT0 and ZT12. RNA was extracted and gene expression panels were used to measure fold change of oxidative stress pathway genes at ZT12 versus ZT0 (n = 3). (C) Bmal1+/+ and Bmal1−/− BMDMs were treated with LPS (100 ng/mL) for 24 h before staining with CellROX. ROS was then measured via flow cytometry (n = 4). (D) Bmal1+/+ and Bmal1−/− BMDMs were untreated or treated with LPS (100 ng/mL) for 24 h before staining with CellROX and MitoTracker green. The cells were imaged using confocal microscopy. Image shown is a representative of at least three independent experiments. Statistical significance of graph A was determined by unpaired Student’s t test. Statistical significance of C was determined by one-way ANOVA. *P ≤ 0.05 and **P ≤ 0.01.CC BY-NC-ND · PubMed Central
Fig. 4. Increased IL-1β production with Bmal1 deletion. (A) Wild-type C57Bl6 mice were injected with PBS or LPS (5 mg/kg) for 90 min at ZT8 or ZT20. Serum was isolated from whole blood and levels of IL-1β were measured by ELISA (n = 10–11). (B) Bmal1myeloid+/+ and Bmal1myeloid−/− mice were injected with PBS or LPS (5 mg/kg) for 90 min at ZT20. Serum was isolated from whole blood and levels of IL-1β were measured by ELISA (n = 6). (C and D) Wild-type BMDMs were transfected with scrambled siRNA or siRNA targeting Nrf2 and treated with LPS (100 ng/mL) for 24 h (n = 3), (C) Il1b mRNA was measured by qPCR, and (D) pro–IL-1β was measured by immunoblot. (E and F) Bmal1+/+ and Bmal1−/− BMDMs were treated with LPS (100 ng/mL) for 24 h, (E) Il1b mRNA was measured by qPCR (n = 8), and (F) pro–IL-1β was measured by immunoblot. (G and H) Bmal1+/+ and Bmal1−/− BMDMs were treated with LPS (100 ng/mL), (G) HIF-1α levels were measured by immunoblot, and (H) Phd3 mRNA was measured by qPCR (n = 4). Immunoblots presented are a representative of at least three independent experiments. Values provided below each lane indicate relative densitometry of each band. Statistical significance of A–C, E, and H was determined by one-way ANOVA. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.
Fig. 4. Increased IL-1β production with Bmal1 deletion. (A) Wild-type C57Bl6 mice were injected with PBS or LPS (5 mg/kg) for 90 min at ZT8 or ZT20. Serum was isolated from whole blood and levels of IL-1β were measured by ELISA (n = 10–11). (B) Bmal1myeloid+/+ and Bmal1myeloid−/− mice were injected with PBS or LPS (5 mg/kg) for 90 min at ZT20. Serum was isolated from whole blood and levels of IL-1β were measured by ELISA (n = 6). (C and D) Wild-type BMDMs were transfected with scrambled siRNA or siRNA targeting Nrf2 and treated with LPS (100 ng/mL) for 24 h (n = 3), (C) Il1b mRNA was measured by qPCR, and (D) pro–IL-1β was measured by immunoblot. (E and F) Bmal1+/+ and Bmal1−/− BMDMs were treated with LPS (100 ng/mL) for 24 h, (E) Il1b mRNA was measured by qPCR (n = 8), and (F) pro–IL-1β was measured by immunoblot. (G and H) Bmal1+/+ and Bmal1−/− BMDMs were treated with LPS (100 ng/mL), (G) HIF-1α levels were measured by immunoblot, and (H) Phd3 mRNA was measured by qPCR (n = 4). Immunoblots presented are a representative of at least three independent experiments. Values provided below each lane indicate relative densitometry of each band. Statistical significance of A–C, E, and H was determined by one-way ANOVA. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.CC BY-NC-ND · PubMed Central
Fig. 5. Boosting NRF2 activity and limiting ROS rescues the IL-1β phenotype of Bmal1-deficient macrophages. Bmal1+/+ and Bmal1−/− BMDMs were transfected with scrambled siRNA or siRNA targeting Keap1 and treated with LPS (100 ng/mL) and (A) NRF2 and HIF-1α were detected by immunoblot following 8 and 24 h of LPS stimulation. (B) Il1b mRNA was measured by qPCR (n = 4). (C) Protein levels of pro–IL-1β were measured by immunoblot. Bmal1+/+ and Bmal1−/− BMDMs were pretreated with either 100 μM DEM or 10 mM NAC before LPS (100 ng/mL) stimulation. (D) Il1b mRNA was measured by qPCR (n = 3) and (E) pro–IL-1β protein levels were measured by immunoblot. Immunoblots presented are a representative of at least three independent experiments. Values provided below each lane indicate relative densitometry of each band. Statistical significance of all graphs was determined by one-way ANOVA. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.
Fig. 5. Boosting NRF2 activity and limiting ROS rescues the IL-1β phenotype of Bmal1-deficient macrophages. Bmal1+/+ and Bmal1−/− BMDMs were transfected with scrambled siRNA or siRNA targeting Keap1 and treated with LPS (100 ng/mL) and (A) NRF2 and HIF-1α were detected by immunoblot following 8 and 24 h of LPS stimulation. (B) Il1b mRNA was measured by qPCR (n = 4). (C) Protein levels of pro–IL-1β were measured by immunoblot. Bmal1+/+ and Bmal1−/− BMDMs were pretreated with either 100 μM DEM or 10 mM NAC before LPS (100 ng/mL) stimulation. (D) Il1b mRNA was measured by qPCR (n = 3) and (E) pro–IL-1β protein levels were measured by immunoblot. Immunoblots presented are a representative of at least three independent experiments. Values provided below each lane indicate relative densitometry of each band. Statistical significance of all graphs was determined by one-way ANOVA. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.CC BY-NC-ND · PubMed Central
Fig. 6. Schematic of proposed model. We observe that the core molecular clock component, BMAL1, is crucial in promoting Nrf2 transcription in myeloid cells. NRF2 can repress IL-1β through two possible mechanisms: direct repression of Il1b transcription or induction of antioxidant response elements. This second pathway results in ROS suppression, which reduces levels of HIF-1α binding to hypoxia response elements (HRE), preventing induction of Il1b transcription. Thus, the molecular clock directly controls NRF2 transcriptional activity and antioxidant capacity to regulate IL-1β in myeloid cells.
Fig. 6. Schematic of proposed model. We observe that the core molecular clock component, BMAL1, is crucial in promoting Nrf2 transcription in myeloid cells. NRF2 can repress IL-1β through two possible mechanisms: direct repression of Il1b transcription or induction of antioxidant response elements. This second pathway results in ROS suppression, which reduces levels of HIF-1α binding to hypoxia response elements (HRE), preventing induction of Il1b transcription. Thus, the molecular clock directly controls NRF2 transcriptional activity and antioxidant capacity to regulate IL-1β in myeloid cells.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 425

Metadata

Authors
Early, J. O., Menon, D., Wyse, C. A., Cervantes-Silva, M. P., Zaslona, Z., Carroll, R. G., Palsson-McDermott, E. M., Angiari, S., Ryan, D. G., Corcoran, S. E., Timmons, G., Geiger, S. S., Fitzpatrick, D. J., O’Connell, D., Xavier, R. J., Hokamp, K., O’Neill, L. A. J., & Curtis, A. M.
Affiliations
  • Royal College of Surgeons in Ireland (IE)
  • Trinity College Dublin (IE)
  • Department of Molecular and Cellular Therapeutics, Tissue Engineering Regenerative Group, Royal College of Surgeons in Ireland, Dublin 2, Ireland;
  • School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland;
  • Broad Institute (US)
Corresponding author
Curtis, Annie M.
Venue
Proceedings of the National Academy of Sciences
Published
2018-08-20
Volume
115
Issue
36
Pages
E8460-E8468
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2888547429
Cited by
389
References
34
Citations by year
2026: 61 · 2025: 54 · 2024: 51 · 2023: 59 · 2022: 57 · 2021: 51 · 2020: 38 · 2019: 15 · 2018: 3
FWCI
15.02
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
  • Figshare (submittedVersion, cc-by-nc-sa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-nd)
Funders
  • Science Foundation Ireland (13/SIRG/2130, 17/CDA/4688)
  • Wellcome (205455)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
Keywords
Bmal1, circadian clock, Nrf2, IL-1β, macrophages, reactive oxygen species, antioxidant response, innate immunity, myeloid cells, inflammatory cytokines
MeSH terms
Animals, Humans, Inflammation, Lipopolysaccharides, Macrophages, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, NF-E2-Related Factor 2, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Interleukin-1beta, ARNTL Transcription Factors, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2. https://app.cochat.ai/papers/10.1073/pnas.1800431115
The paper
Early, J. O., Menon, D., Wyse, C. A., Cervantes-Silva, M. P., Zaslona, Z., Carroll, R. G., Palsson-McDermott, E. M., Angiari, S., Ryan, D. G., Corcoran, S. E., Timmons, G., Geiger, S. S., Fitzpatrick, D. J., O’Connell, D., Xavier, R. J., Hokamp, K., O’Neill, L. A. J., & Curtis, A. M. (2018). Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1800431115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.